Gudarz Davar

Gudarz Davar is a highly experienced leader in the pharmaceutical industry, currently serving as a Board Member and Advisor at Kisbee Therapeutics and holding the position of EVP, Head of Research and Development, and CMO at Autobahn Therapeutics, Inc. Previously, Gudarz Davar was EVP, Head of Research and Development at ACADIA Pharmaceuticals Inc., where oversight was provided for a large R&D team and various global programs. Prior roles include Vice President of Neurology Development at Eli Lilly and Company, Section Head at Allergan, Director of Neurology at Biogen Idec, and several positions at Amgen. Gudarz Davar's academic background includes an MD from Dalhousie University, with further studies at McGill University and Harvard Medical School. Academic and clinical contributions include significant research in pain signaling and the development and approval of prominent neurologic therapies.